Go Pro

Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$12.66 +0.32 (+2.55%)
As of 01:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

DRTS vs. LIVN, NVST, MMED, IRTC, and WRBY

Should you buy Alpha Tau Medical stock or one of its competitors? MarketBeat compares Alpha Tau Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Tau Medical include LivaNova (LIVN), Envista (NVST), MiniMed Group (MMED), iRhythm Technologies (IRTC), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry.

How does Alpha Tau Medical compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

LivaNova has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

Alpha Tau Medical has lower revenue, but higher earnings than LivaNova. Alpha Tau Medical is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.39B3.17-$242.47M$1.9541.11
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

LivaNova has a net margin of 7.48% compared to Alpha Tau Medical's net margin of 0.00%. LivaNova's return on equity of 16.48% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova7.48% 16.48% 7.59%
Alpha Tau Medical N/A -73.23%-52.90%

97.6% of LivaNova shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 0.4% of LivaNova shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

LivaNova currently has a consensus price target of $81.38, indicating a potential upside of 1.52%. Alpha Tau Medical has a consensus price target of $12.60, indicating a potential downside of 0.31%. Given LivaNova's stronger consensus rating and higher possible upside, research analysts plainly believe LivaNova is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29

In the previous week, LivaNova and LivaNova both had 3 articles in the media. LivaNova's average media sentiment score of 1.51 beat Alpha Tau Medical's score of 0.66 indicating that LivaNova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LivaNova beats Alpha Tau Medical on 11 of the 14 factors compared between the two stocks.

How does Alpha Tau Medical compare to Envista?

Alpha Tau Medical (NASDAQ:DRTS) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

Envista has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
Envista$2.72B1.59$47M$0.4164.73

Alpha Tau Medical has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Alpha Tau Medical currently has a consensus target price of $12.60, indicating a potential downside of 0.31%. Envista has a consensus target price of $28.54, indicating a potential upside of 7.53%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38

Envista has a net margin of 2.41% compared to Alpha Tau Medical's net margin of 0.00%. Envista's return on equity of 7.11% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
Envista 2.41%7.11%3.91%

2.7% of Alpha Tau Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Envista had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 4 mentions for Envista and 3 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 0.66 beat Envista's score of 0.65 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Envista beats Alpha Tau Medical on 11 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to MiniMed Group?

Alpha Tau Medical (NASDAQ:DRTS) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

In the previous week, MiniMed Group had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for MiniMed Group and 3 mentions for Alpha Tau Medical. MiniMed Group's average media sentiment score of 0.81 beat Alpha Tau Medical's score of 0.66 indicating that MiniMed Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MiniMed Group
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 19.7% of MiniMed Group shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 2.2% of MiniMed Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Alpha Tau Medical presently has a consensus target price of $12.60, indicating a potential downside of 0.31%. MiniMed Group has a consensus target price of $21.33, indicating a potential upside of 36.68%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.73

Alpha Tau Medical has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
MiniMed Group$3.10B1.41-$190.97M-$0.68N/A

MiniMed Group's return on equity of 0.00% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
MiniMed Group N/A N/A N/A

Summary

MiniMed Group beats Alpha Tau Medical on 9 of the 13 factors compared between the two stocks.

How does Alpha Tau Medical compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, iRhythm Technologies and iRhythm Technologies both had 3 articles in the media. Alpha Tau Medical's average media sentiment score of 0.66 beat iRhythm Technologies' score of 0.62 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alpha Tau Medical has a net margin of 0.00% compared to iRhythm Technologies' net margin of -3.53%. iRhythm Technologies' return on equity of -10.26% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-3.53% -10.26% -1.39%
Alpha Tau Medical N/A -73.23%-52.90%

iRhythm Technologies currently has a consensus price target of $187.38, suggesting a potential upside of 62.45%. Alpha Tau Medical has a consensus price target of $12.60, suggesting a potential downside of 0.31%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe iRhythm Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29

2.7% of Alpha Tau Medical shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Alpha Tau Medical has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$747.14M5.07-$44.55M-$0.86N/A
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

Summary

iRhythm Technologies beats Alpha Tau Medical on 8 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to Warby Parker?

Alpha Tau Medical (NASDAQ:DRTS) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Alpha Tau Medical currently has a consensus target price of $12.60, suggesting a potential downside of 0.31%. Warby Parker has a consensus target price of $29.82, suggesting a potential upside of 5.03%. Given Warby Parker's stronger consensus rating and higher probable upside, analysts plainly believe Warby Parker is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67

Warby Parker has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
Warby Parker$871.91M3.49$1.64M$0.021,419.55

Alpha Tau Medical has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market.

Warby Parker has a net margin of 0.15% compared to Alpha Tau Medical's net margin of 0.00%. Warby Parker's return on equity of 2.30% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
Warby Parker 0.15%2.30%1.18%

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 3 articles in the media. Alpha Tau Medical's average media sentiment score of 0.66 beat Warby Parker's score of 0.41 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Warby Parker beats Alpha Tau Medical on 12 of the 14 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.14B$7.48B$6.79B$12.62B
Dividend YieldN/A1.31%2.68%8.43%
P/E Ratio-18.8750.4027.0424.39
Price / SalesN/A45.19521.7491.34
Price / CashN/A26.3148.5959.39
Price / Book14.367.2210.836.31
Net Income-$42.63M$162.30M$3.59B$331.45M
7 Day Performance-1.10%0.67%-1.30%0.26%
1 Month Performance30.70%-0.31%2.97%-0.64%
1 Year Performance301.24%7.75%28.58%20.24%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
1.5371 of 5 stars
$12.66
+2.6%
$12.60
-0.4%
+282.0%$1.14BN/AN/A80
LIVN
LivaNova
1.8978 of 5 stars
$83.58
-0.5%
$80.75
-3.4%
+79.9%$4.62B$1.39B42.863,300
NVST
Envista
2.2422 of 5 stars
$27.16
-1.3%
$28.67
+5.5%
+30.4%$4.48B$2.72B66.2512,000
MMED
MiniMed Group
2.6794 of 5 stars
$15.37
+0.5%
$21.33
+38.8%
N/A$4.32B$3.10BN/A8,000
IRTC
iRhythm Technologies
3.7993 of 5 stars
$125.09
-0.7%
$187.38
+49.8%
-19.0%$4.14B$747.14MN/A2,400

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners